X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former
X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former management for the fiscal years 1997 through the third quarter of fiscal 2000. The terms of the settlement are subject to approval by the U.S. District Court for the Southern District of New York. Del Global signed a consent decree with the SEC in December involving payment of a civil penalty of $400,000. The company is primarily engaged in the design, manufacture, and marketing of x-ray systems for the medical and dental markets, as well as high-voltage power conversion subsystems for medical and other industrial applications.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.